Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Steps in Outbreak Investigation01:18

Steps in Outbreak Investigation

131
In the ever-evolving field of public health, statistical analysis serves as a cornerstone for understanding and managing disease outbreaks. By leveraging various statistical tools, health professionals can predict potential outbreaks, analyze ongoing situations, and devise effective responses to mitigate impact. For that to happen, there are a few possible stages of the analysis:
131
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

195
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
195
Mechanistic Models: Compartment Models in Individual and Population Analysis01:23

Mechanistic Models: Compartment Models in Individual and Population Analysis

43
Mechanistic models are utilized in individual analysis using single-source data, but imperfections arise due to data collection errors, preventing perfect prediction of observed data. The mathematical equation involves known values (Xi), observed concentrations (Ci), measurement errors (εi), model parameters (ϕj), and the related function (ƒi) for i number of values. Different least-squares metrics quantify differences between predicted and observed values. The ordinary least...
43
Hazard Ratio01:12

Hazard Ratio

130
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
130

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Chronic disease related emergency department presentations and potential for redirection to alternative acute care settings ("FOCUS" study): A nationwide flashmob study.

PloS one·2026
Same author

Patient-Physician Agreement on Diagnosis in the ED, Part of Diagnostic Excellence. A Prospective Multicenter Study.

Academic emergency medicine : official journal of the Society for Academic Emergency Medicine·2026
Same author

Flow-Cytometric Guidance of High-Dose Anti-D Prophylaxis in Massive Fetomaternal Hemorrhage: A Case Report.

International journal of laboratory hematology·2026
Same author

Analytical Performance Evaluation of the Cardiac Troponin T High Sensitivity Gen 6 Assay.

The journal of applied laboratory medicine·2026
Same author

Characterization of participants with a disproportionate degree of hypertension-mediated organ damage: the Maastricht study.

Journal of hypertension·2026
Same author

Cardiac Biomarker Kinetics in Patients after Coronary Artery Bypass Grafting with an Uncomplicated Course.

Clinical chemistry·2026

相关实验视频

Updated: Jul 8, 2025

Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack
07:31

Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack

Published on: May 15, 2020

7.1K

可解释的机器学习模型用于紧急部门的快速风险分层:一个多中心研究.

William P T M van Doorn1,2, Floris Helmich3, Paul M E L van Dam4

  • 1Central Diagnostic Laboratory, Department of Clinical Chemistry, Maastricht University Medical Center, Maastricht, the Netherlands.

The journal of applied laboratory medicine
|December 15, 2023
PubMed
概括

机器学习使用实验室数据准确预测急诊室患者的31天死亡风险. 该工具增强了风险分层,并有助于临床决策,以获得更好的患者结果.

更多相关视频

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
12:18

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment

Published on: January 11, 2020

7.6K
Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
04:09

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

8.3K

相关实验视频

Last Updated: Jul 8, 2025

Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack
07:31

Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack

Published on: May 15, 2020

7.1K
A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
12:18

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment

Published on: January 11, 2020

7.6K
Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
04:09

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

8.3K

科学领域:

  • 医疗信息学 医疗信息学
  • 医疗保健中的机器学习
  • 临床决策支持 临床决策支持

背景情况:

  • 紧急部门 (ED) 的风险分层对于患者分类至关重要.
  • 诊断性实验室测试对于评估患者的风险至关重要.
  • 机器学习可以显著提高这些测试的预后能力.

研究的目的:

  • 开发一个准确和可解释的机器学习模型来预测ED患者的31天死亡率.
  • 创建一个临床决策支持工具,名为RISKINDEX.
  • 评估该工具在多个荷兰医院的性能.

主要方法:

  • 机器学习模型在患者特征和实验室数据上受训,从ED呈现的前2小时开始.
  • 来自荷兰三个主要医疗中心的数据跨越了5年.
  • 模型评估使用了接收器运行特征曲线 (AUROC) 和校准曲线下的面积,并对模型可解释性进行了沙普利增量解释 (SHAP).

主要成果:

  • 这项研究分析了266,327名患者和710万份实验室结果.
  • 风险指数模型显示了高诊断性能,AUROC在各医院的范围从0.88到0.98不等.
  • SHAP分析提供了对患者数据的洞察力,推动了个体预测.

结论:

  • 开发的临床决策支持工具在预测ED患者31天死亡率方面表现出色的诊断性能.
  • 进一步的研究将专注于实施这些算法以改善临床结果.
  • 风险指数工具提供了一个有希望的方法,通过数据驱动的洞察力来增强紧急护理.